Default object view. Click to create a custom template, Node ID: 139211, Object ID: 82278

Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab v...

Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX

No relation

Yes

No relation

No

21/03/2016 2:48 pm

No